October 5, 2020

A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms

Category: Article Summary

Topic: Testing and Treatment

Keywords (Tags): testing

• [Preprint, not peer-reviewed] A nanoparticle-enabled blood test could detect a statistically significant differences in immune response between samples collected from COVID-19 patients with no or mild symptoms (n=38) and those with moderate/severe symptoms (n=115), with results available in <1 minute. The authors conclude this new rapid test may be used as a point-of-care clinical tool for COVID-19 patient risk stratification and management.

Deb et al. (Oct 2, 2020). A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms. Preprint downloaded Oct 5 from https://doi.org/10.1101/2020.09.30.20203844